We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
A key tenet of JDRF’s research funding strategy is that there are multiple pathways to cures for type 1 diabetes (T1D), one of which includes screening for risk and use of therapeutics to delay or even prevent the onset of the disease developing – to give more time to the individual to adapt before requiring […]
Karoliina Tuomela is a postdoctoral researcher at the JDRF Centre of Excellence at the University of British Columbia, and the first recipient of a J. Andrew McKee Fellowship in Type 1 Diabetes (T1D), jointly funded by JDRF Canada and the Stem Cell Network (SCN) based at the JDRF Centre of Excellence at the University of […]
This blog contains content relating to early mortality due to Type 1 Diabetes, which may be confronting and distressing to some readers. Please exercise caution and care when engaging with this content. How many people live with type 1 diabetes (T1D) around the globe? How does T1D affect life expectancy? How many lives could be […]
September 23, 2022 JDRF is deeply saddened by the loss of an incredible individual who made an unparalleled impact at JDRF, Peter Oliver. “Peter possessed a multitude of qualities that defined him as a leader – visionary, credible, trustworthy, respectful, influential, and empowering are just a few of these traits,” said Dave Prowten, President and CEO […]
The following is sponsored content developed in partnership with AMG Medical Low blood glucose—also known as hypoglycemia—can be one of the most challenging, stressful, and often scary parts of living with diabetes. Learning how to treat hypoglycemia is very important. If you live with type 1 diabetes (T1D), you know that being prepared for low […]
JDRF’s #AccessForAll advocacy campaign aims to make type 1 diabetes (T1D) technology affordable and accessible for all Canadians living with the disease. With support from the T1D community, JDRF seeks to increase public and private coverage technologies such as continuous glucose monitors (CGM) and flash glucose monitors (Flash GM). The goal is to reduce the […]
JDRF Canada is thrilled to partner with Michael Smith Health Research BC to award type 1 diabetes (T1D) researcher Dr. Tricia Tang a Health Research BC Health Professional-Investigator (HP-I) award. A key focus of JDRF is improving the mental health outcomes for people living with type 1 diabetes (T1D). Part of this is creating research […]
JDRF congratulates the McGill University Health Centre (MUHC) on its recent mandate to provide islet transplantation for persons with T1D in Quebec. This designation by Quebec’s Ministry of Health and Social Services recognizes the clinical and research teams at MUHC for their leadership and dedication in the field of islet transplantation. As one of only […]
Sébastien was diagnosed with type 1 diabetes (T1D) in 2002. He made a commitment to himself then that T1D would never keep him from living life to the fullest, and he has followed through on that promise to himself. Since then, Seb has run across Canada, climbed Mt Everest, and participated in a number of […]
Update: July 15, 2022 On Thursday, July 14, 2022 Health Canada approved the Moderna Spikevax Covid-19 vaccine for children aged six months to five years old. This makes approximately 1.7 million Canadian children eligible for vaccination. Health Canada has authorized a two-dose primary series of 25 micrograms each, with the second dose to be administered […]
On Monday July 11, 2022, Vertex Pharmaceuticals announced they acquired ViaCyte for $320 million in cash to help speed up the development of VX-880, Vertex’s stem cell-derived therapy for people with type 1 diabetes (T1D). What does this mean for Canadians living with type 1 diabetes? T1D is an autoimmune disorder where the body destroys […]
It often starts with one and becomes a reality with the support of many: one step to begin a walk, one truck to build a transport empire, and one idea to create a leading global charity. Like JDRF, Armour Transport Systems arose from humble beginnings in the 1940s, when Mr. Gordon Armour used his truck […]
Notifications
